Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Non-Current Assets (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Non-Current Assets for 4 consecutive years, with $909000.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 9.37% to $909000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, down 37.28% year-over-year, with the annual reading at $909000.0 for FY2025, 9.37% down from the prior year.
  • Non-Current Assets for Q4 2025 was $909000.0 at Spruce Biosciences, up from $797000.0 in the prior quarter.
  • The five-year high for Non-Current Assets was $19.9 million in Q1 2022, with the low at $797000.0 in Q3 2025.
  • Average Non-Current Assets over 4 years is $3.1 million, with a median of $1.7 million recorded in 2023.
  • The sharpest move saw Non-Current Assets crashed 90.56% in 2023, then decreased 9.37% in 2025.
  • Over 4 years, Non-Current Assets stood at $2.0 million in 2022, then dropped by 13.58% to $1.8 million in 2023, then crashed by 43.11% to $1.0 million in 2024, then decreased by 9.37% to $909000.0 in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $909000.0, $797000.0, and $867000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.